# FDA Inspection 1203306 - Alembic Pharmaceuticals Limited - March 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited/1c3f747a-744a-4122-ae90-164ef47527bc
Source feed: FDA_Inspections

> FDA Inspection 1203306 for Alembic Pharmaceuticals Limited on March 10, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203306
- Company Name: Alembic Pharmaceuticals Limited
- Inspection Date: 2023-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1118669 - 2020-01-08](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited/2c73460a-0a40-4d9c-b70f-b1a1417b709f)

Company: https://www.keypedia.com/companies/alembic-pharmaceuticals-limited/378b93aa-98ff-4894-93aa-5e799d703e62

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c